Cleared Traditional

K213953 - BD Vacutainer® Trace Element K2EDTA Tubes, BD Vacutainer® Trace Element Serum Tubes (FDA 510(k) Clearance)

Jul 2023
Decision
577d
Days
Class 2
Risk

K213953 is an FDA 510(k) clearance for the BD Vacutainer® Trace Element K2EDTA Tubes, BD Vacutainer® Trace Element Serum Tubes. This device is classified as a Tubes, Vials, Systems, Serum Separators, Blood Collection (Class II - Special Controls, product code JKA).

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on July 17, 2023, 577 days after receiving the submission on December 17, 2021.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1675.

Submission Details

510(k) Number K213953 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 17, 2021
Decision Date July 17, 2023
Days to Decision 577 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JKA — Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1675

Similar Devices — JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 16
BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes
K252040 · Becton, Dickinson and Company · Mar 2026
BD Vacutainer® Eclipse™ Blood Collection Needle
K243207 · Becton, Dickinson and Company · Jul 2025
Blood collection tube holders
K250961 · Promisemed Hangzhou Meditech Co., Ltd. · Jun 2025
BD Vacutainer® Multiple Sample Luer Adapter
K243649 · Becton, Dickinson and Company · Mar 2025
PIVO™ Pro Needle-free Blood Collection Device
K241586 · Becton Dickinson Infusion Therapy Systems, Inc. · Feb 2025
BD Vacutainer® One Use Holder
K242320 · Becton, Dickinson and Company · Nov 2024